Abstract

Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries

Camacho-Soto A1, Gross A1, Searles Nielsen S1, Dey N2, Racette BA3. Parkinsonism Relat Disord. 2018 Feb 9. pii: S1353-8020(18)30044-0. doi: 10.1016/j.parkreldis.2018.02.008. [Epub ahead of print]
 
     

Author information

1 Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States.

2 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.

3 Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: racetteb@wustl.edu.

Abstract

INTRODUCTION: Gastrointestinal (GI) dysfunction precedes the motor symptoms of Parkinson's disease (PD) by several years. PD patients have abnormal aggregation of intestinal α-synuclein, the accumulation of which may be promoted by inflammation. The relationship between intestinal α-synuclein aggregates and central nervous system neuropathology is unknown. Recently, we observed a possible inverse association between inflammatory bowel disease (IBD) and PD as part of a predictive model of PD. Therefore, the objective of this study was to examine the relationship between PD risk and IBD and IBD-associated conditions and treatment.

METHODS: Using a case-control design, we identified 89,790 newly diagnosed PD cases and 118,095 population-based controls >65 years of age using comprehensive Medicare data from 2004-2009 including detailed claims data. We classified IBD using International Classification of Diseases version 9 (ICD-9) diagnosis codes. We used logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs) to evaluate the association between PD and IBD. Covariates included age, sex, race/ethnicity, smoking, Elixhauser comorbidities, and health care use.

RESULTS: PD was inversely associated with IBD overall (OR = 0.85, 95% CI 0.80-0.91) and with both Crohn's disease (OR = 0.83, 95% CI 0.74-0.93) and ulcerative colitis (OR = 0.88, 95% CI 0.82-0.96). Among beneficiaries with ≥2 ICD-9 codes for IBD, there was an inverse dose-response association between number of IBD ICD-9 codes, as a potential proxy for IBD severity, and PD (p-for-trend = 0.006).

CONCLUSION: IBD is associated with a lower risk of developing PD.

© Copyright 2013-2018 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.